Clinic
Gateway Urgent Care, LLC
Gateway Urgent Care, LLC was paid $4.11M by Medicaid between Jan 2018 and Dec 2024, across 30 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoGATEWAY URGENT CARE, LLC
OWENSBORO, KY 42303
OWENSBORO, KY 42303
33aNPI1124325865assigned 02/15/2011
33bProvider typeUrgent Care Clinic/Center
28Total paid$4.11M
24GClaims124,170
24DCodes billed30
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Kentucky
Rank by total paid#3 of 13
Median peer was paid$254K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,407 | $334K | |
| 2019 | 12,171 | $540K | |
| 2020 | 10,328 | $477K | |
| 2021 | 18,742 | $581K | |
| 2022 | 26,773 | $721K | |
| 2023 | 25,756 | $802K | |
| 2024incomplete | 18,993 | $654K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 40,365 | 37,275 | $1.73M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 19,537 | 18,148 | $551K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 10% | 1,738 | 1,652 | $415K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.8% | 5,224 | 4,910 | $363K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.0% | 12,542 | 11,257 | $246K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.6% | 4,675 | 4,398 | $231K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.3% | 12,340 | 11,520 | $219K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 5,793 | 5,212 | $72K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 6,844 | 6,417 | $69K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,713 | 1,631 | $35K |
| 87581 | <1% | 1,717 | 1,631 | $35K | |
| 87486 | <1% | 1,709 | 1,628 | $35K |
18 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,034 | $23K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 725 | $23K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 631 | $17K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 214 | $13K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 350 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 442 | $7K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 415 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,431 | $5K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 106 | $4K |
| 87807 | <1% | 184 | $2K | |
| 87428 | <1% | 76 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 53 | $1K |
| 90686 | <1% | 54 | $916.17 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 62 | $671.04 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 192 | $620.59 |
| 81002 | <1% | 1,945 | $587.38 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 31 | $149.90 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 28 | $4.68 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCNULTY, JOHN (PART OWNER)
| Provider | Location | Paid |
|---|---|---|
| Newburgh Urgent Care LLC | Newburgh, IN | $6.15M |
| Gateway Primary Care, LLC | Owensboro, KY | $172K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.